Viewing Study NCT03616834


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2026-02-28 @ 8:59 AM
Study NCT ID: NCT03616834
Status: COMPLETED
Last Update Posted: 2023-03-22
First Post: 2018-07-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy
Sponsor: Effector Therapeutics
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: eFT508-0010
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators